Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Hepatitis C (HCV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Hepatitis C (HCV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Hepatitis C (HCV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 345 of 345 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Smoking Notes | Symptoms | ICD10 codes | Risk Categories | Bio-Rad GD HBsAg EIA 3.0 | MONOLISA Anti-HBC IgM EIA | Date of Freeze | Anti HSV 1 IgG Quantitative | Anti HSV 2 IgG | Anti HSV 2 IgG Quantitative | N. Gonorrhoeae | Treponema pallidum ab | C. Trachomatis | HIV 1| 2 Ag|Ab Combo | Roche cobas TaqScreen MPX | Abbott PRISM | RNA Quant: | 3-series HepB Vaccine | Is Subject on Anti-Viral Therapy / Treatment | Acquired Infection Category | Additional Testing | Hepatitis Serology | Co-Infections | Real Time PCR | Other Testing Results | HCV RIBA Pattern | hSOD Results | Prism | Elisa | Innolia | DGV | DGV Ultrio | Axsym | Additional Results | Roche cobas TaqScreen | Arlington Scientific Card Test |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBP0000-AC900106674041213DD | Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 6.00 | $200.00 | 30 Y | Male | Unknown | <-70C | 12-Apr-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Fatigue; Elevated LFTs | Intravenous drug user; Body punctures | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| BBP0000-BU900106673043013DD | Hepatitis C (HCV) | United States | Plasma | 1.00 | 5.00 | $200.00 | 48 Y | Female | Non-Hispanic | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Vomiting; Abdominal pains; Elevated LFTs | Sexual contacts of HBV or HCV infected person; Body punctures (Piercing, human bite) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| BBS0000-AI900108429041718DD | Hepatitis C (HCV) | United States | Serum | 1.75 | 1.00 | $75.00 | 61 Y | Female | Non-Hispanic | <-70C | 17-Apr-18 | Roche COBAS | Taqman | 142,170 IU/mL | HCV Viral Load | $75.00 | Unknown | B19.2 | 05.15.18 | |||||||||||||||||||||||||||||||||||||||||||
| BBS0000-DN900090663030718DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 42 Y | Female | Unknown | <-70C | 07-Mar-18 | Roche cobas 602 | ECLIA | 0.03 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 15.1 | Positive | 1.91 | Not Detected | Negative | Not Detected | ||||||||||||||||||||||||||||||||||||
| BBS0000-DN900090676040618DD | Hepatitis C (HCV) | Serum | 1.00 | 1.00 | $75.00 | 29 Y | Female | Unknown | <-70C | 06-Apr-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Negative | $75.00 | Unknown | 0.634 | Negative | 0.114 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900092135030918DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 39 Y | Female | Unknown | <-70C | 09-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-DN900092513032318DD | Hepatitis C (HCV) | Serum | 1.00 | 1.00 | $75.00 | 29 Y | Female | Unknown | <-70C | 23-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-DN900096000031918DD | Hepatitis C (HCV) | Serum | 1.00 | 1.00 | $75.00 | 21 Y | Female | Unknown | <-70C | 19-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 30.9 | Positive | 2.02 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900096005032918DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 66 Y | Female | Unknown | <-70C | 29-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 41.5 | Negative | 0.579 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900096912032018DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 40 Y | Female | Unknown | <-70C | 20-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 21.4 | Positive | 7.86 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900096921030718DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 51 Y | Male | Unknown | <-70C | 07-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 44.2 | Negative | 0.0954 | Not Detected | Negative | Not Detected | ||||||||||||||||||||||||||||||||||||
| BBS0000-DN900096992032018DD | Hepatitis C (HCV) | Serum | 1.25 | 1.00 | $75.00 | 54 Y | Male | Unknown | <-70C | 20-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Negative | $75.00 | Unknown | 0.135 | Positive | 4.11 | Not Detected | Negative | Not Detected | U/A | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900097236032318DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 55 Y | Female | Unknown | <-70C | 23-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-DN900097241040518DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 17 Y | Female | Unknown | <-70C | 05-Apr-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Negative | $75.00 | Unknown | 0.337 | Negative | 0.26 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900097443033018DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 39 Y | Female | Unknown | <-70C | 30-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 31.1 | Negative | 0.118 | U/A | Negative | U/A | U/A | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900097836030818DD | Hepatitis C (HCV) | Serum | 1.25 | 1.00 | $75.00 | 27 Y | Female | Unknown | <-70C | 08-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 30.1 | Positive | 6.12 | Not Detected | Negative | Not Detected | ||||||||||||||||||||||||||||||||||||
| BBS0000-DN900098062032218DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 56 Y | Female | Unknown | <-70C | 22-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 1.19 | Negative | 0.174 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900098068040618DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 29 Y | Female | Unknown | <-70C | 06-Apr-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | U/A | $75.00 | Unknown | U/A | U/A | U/A | U/A | U/A | U/A | U/A | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900098512031218DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 20 Y | Female | Unknown | <-70C | 12-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 50.5 | Positive | 6.86 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900098788030918DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 20 Y | Female | Unknown | <-70C | 09-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||||
| BBS0000-DN900098804040518DD | Hepatitis C (HCV) | Serum | 1.25 | 1.00 | $75.00 | 26 Y | Female | Unknown | <-70C | 05-Apr-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 50.1 | Negative | 0.0681 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900098809040518DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 32 Y | Female | Unknown | <-70C | 05-Apr-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 47.8 | Negative | 0.0987 | U/A | Negative | U/A | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900108655032318DD | Hepatitis C (HCV) | Serum | 1.00 | 1.00 | $75.00 | 17 Y | Female | Unknown | <-70C | 23-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 1.52 | Negative | 0.22 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0000-DN900111711031618DD | Hepatitis C (HCV) | Serum | 1.50 | 1.00 | $75.00 | 29 Y | Female | Unknown | <-70C | 16-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Negative | $75.00 | Unknown | <0.0100 | Negative | 0.0532 | U/A | Negative | U/A | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-AC900069461100112DD | Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 57 Y | Female | Unknown | <-70C | 01-Oct-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Jaundice; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | Multiple sex partners; Transplant / transfusion of unscreened blood or blood products (prior to 1992) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900047459123008DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 9.00 | $75.00 | 38 Y | Male | Non-Hispanic | <-70C | 30-Dec-08 | Roche COBAS AmpliScreen HCV | Positive | HCV AB | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900047461051309DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 6.00 | $75.00 | 27 Y | Male | Hispanic | <-70C | 13-May-09 | Roche COBAS AmpliScreen HCV | Positive | HCV AB | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900047463062409DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 4.00 | $75.00 | 33 Y | Female | Non-Hispanic | <-70C | 24-Jun-09 | Roche COBAS AmpliScreen HCV | Positive | HCV AB | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900047464071309DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 21.00 | $75.00 | Male | Unknown | <-70C | 13-Jul-09 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900047465071509DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 11.00 | $75.00 | 18 Y | Male | Non-Hispanic | <-70C | 15-Jul-09 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900047466081209DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 6.00 | $75.00 | Male | Unknown | <-70C | 12-Aug-09 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900047467073009DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 11.00 | $75.00 | 36 Y | Male | Hispanic | <-70C | 30-Jul-09 | Roche COBAS AmpliScreen HCV | Positive | HCV AB | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900050549091509DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 17.00 | $75.00 | 39 Y | Male | Non-Hispanic | <-70C | 15-Sep-09 | Roche COBAS AmpliScreen HCV | Positive | HCV AB | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900050551063009DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 5.00 | $75.00 | 47 Y | Male | Non-Hispanic | <-70C | 30-Jun-09 | Roche COBAS AmpliScreen HCV | Positive | HCV AB | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900050553120109DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 2.00 | $75.00 | 35 Y | Male | Non-Hispanic | <-70C | 01-Dec-09 | Roche COBAS AmpliScreen HCV | Positive | HCV AB | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AH900050555041510DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 5.00 | 4.00 | $75.00 | 31 Y | Male | Non-Hispanic | <-70C | 15-Apr-10 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900024362082318DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 16 Y | Female | Non-Hispanic | <-70C | 23-Aug-18 | Abbott Architect | Negative | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900024363082318DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 17 Y | Female | Non-Hispanic | <-70C | 23-Aug-18 | Abbott Architect | Negative | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900024366082318DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 17 Y | Female | Non-Hispanic | <-70C | 23-Aug-18 | Abbott Architect | Negative | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900039928110618DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 27 Y | Female | Non-Hispanic | <-70C | 06-Nov-18 | Abbott Architect | 15.09 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900043595081618DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 16 Y | Female | Non-Hispanic | <-70C | 16-Aug-18 | Abbott Architect | Negative | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900043597081718DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 16 Y | Female | Non-Hispanic | <-70C | 17-Aug-18 | Abbott Architect | Negative | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900043600082218DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 16 Y | Female | Non-Hispanic | <-70C | 22-Aug-18 | Abbott Architect | Negative | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900050060012619DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 21 Y | Female | Non-Hispanic | <-70C | 26-Jan-19 | Abbott Architect | 14.61 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900050061012519DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 30 Y | Male | Non-Hispanic | <-70C | 25-Jan-19 | Abbott Architect | 13.65 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900056554122018DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 75 Y | Female | Non-Hispanic | <-70C | 20-Dec-18 | Abbott Architect | 2.47 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900058064012819DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 47 Y | Male | Non-Hispanic | <-70C | 28-Jan-19 | Abbott Architect | 15.76 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900058065012819DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 18 Y | Female | Non-Hispanic | <-70C | 28-Jan-19 | Abbott Architect | 14.62 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900058069012219DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 68 Y | Male | Non-Hispanic | <-70C | 22-Jan-19 | Abbott Architect | 11.19 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900059778111418DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 61 Y | Male | Non-Hispanic | <-70C | 14-Nov-18 | Abbott Architect | 10.89 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900059779111218DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 40 Y | Female | Non-Hispanic | <-70C | 12-Nov-18 | Abbott Architect | 5.03 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900059780110918DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 57 Y | Male | Non-Hispanic | <-70C | 09-Nov-18 | Abbott Architect | 14.49 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900060180120717DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 31 Y | Male | Non-Hispanic | <-70C | 07-Dec-17 | PCR | Positive | HCV | $75.00 | Unknown | 493 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900064234112918DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 59 Y | Female | Non-Hispanic | <-70C | 29-Nov-18 | Abbott Architect | 1.18 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900064235112918DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 27 Y | Male | Non-Hispanic | <-70C | 29-Nov-18 | Abbott Architect | 2.13 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900064236112718DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 32 Y | Male | Unknown | <-70C | 27-Nov-18 | Abbott Architect | 11.59 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900064237112718DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 31 Y | Male | Non-Hispanic | <-70C | 27-Nov-18 | Abbott Architect | 14.03 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900064244113018DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 68 Y | Female | Non-Hispanic | <-70C | 30-Nov-18 | Abbott Architect | 11.72 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065903112817DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 59 Y | Male | Non-Hispanic | <-70C | 28-Nov-17 | PCR | Positive | HCV | $75.00 | Unknown | 1,759,606 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065904112817DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 49 Y | Male | Non-Hispanic | <-70C | 28-Nov-17 | PCR | Positive | HCV | $75.00 | Unknown | 135 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065907070217DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 50 Y | Male | Non-Hispanic | <-70C | 02-Jul-17 | PCR | Positive | HCV | $75.00 | Unknown | 935,341 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065908101217DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 41 Y | Male | Non-Hispanic | <-70C | 12-Oct-17 | PCR | Positive | HCV | $75.00 | Unknown | 21,448 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065909090717DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 58 Y | Male | Non-Hispanic | <-70C | 07-Sep-17 | PCR | Positive | HCV | $75.00 | Unknown | 1,210,800 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065910070717DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 57 Y | Female | Non-Hispanic | <-70C | 07-Jul-17 | PCR | Positive | HCV | $75.00 | Unknown | 658,254 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065911103117DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 63 Y | Female | Non-Hispanic | <-70C | 31-Oct-17 | PCR | Positive | HCV | $75.00 | Unknown | 252,621 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065912112917DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 34 Y | Female | Non-Hispanic | <-70C | 29-Nov-17 | PCR | Positive | HCV | $75.00 | Unknown | 2,681 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065913090517DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 39 Y | Male | Non-Hispanic | <-70C | 05-Sep-17 | PCR | Positive | HCV | $75.00 | Unknown | 755,739 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065914090517DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 56 Y | Male | Non-Hispanic | <-70C | 05-Sep-17 | PCR | Positive | HCV | $75.00 | Unknown | 4,.339,277 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065915090117DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 52 Y | Male | Non-Hispanic | <-70C | 01-Sep-17 | PCR | Positive | HCV | $75.00 | Unknown | 242,154 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065916101717DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 35 Y | Female | Non-Hispanic | <-70C | 17-Oct-17 | PCR | Positive | HCV | $75.00 | Unknown | 99,538 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065917091217DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 55 Y | Male | Unknown | <-70C | 12-Sep-17 | PCR | Positive | HCV | $75.00 | Unknown | 11,225,008 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065918071917DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 35 Y | Female | Non-Hispanic | <-70C | 19-Jul-17 | PCR | Positive | HCV | $75.00 | Unknown | 21,559 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065919063017DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 47 Y | Female | Non-Hispanic | <-70C | 30-Jun-17 | PCR | Positive | HCV | $75.00 | Unknown | 765 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900065920070617DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 64 Y | Female | Non-Hispanic | <-70C | 06-Jul-17 | PCR | Positive | HCV | $75.00 | Unknown | 2,102,282 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900073642070717DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 47 Y | Female | Unknown | <-70C | 07-Jul-17 | PCR | Positive | HCV | $75.00 | Unknown | 313,876 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076447110218DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.75 | 1.00 | $75.00 | 58 Y | Male | Non-Hispanic | <-70C | 02-Nov-18 | Abbott Architect | 15.44 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076448111018DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 23 Y | Female | Non-Hispanic | <-70C | 10-Nov-18 | Abbott Architect | 12.94 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076449111018DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 50 Y | Female | Non-Hispanic | <-70C | 10-Nov-18 | Abbott Architect | 13.77 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076450111118DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 56 Y | Male | Non-Hispanic | <-70C | 11-Nov-18 | Abbott Architect | 8.93 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076451111318DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 56 Y | Female | Non-Hispanic | <-70C | 13-Nov-18 | Abbott Architect | 11.38 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076452111618DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 55 Y | Female | Non-Hispanic | <-70C | 16-Nov-18 | Abbott Architect | 13.97 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076453111318DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 26 Y | Male | Non-Hispanic | <-70C | 13-Nov-18 | Abbott Architect | 13.53 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076454111518DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 32 Y | Male | Unknown | <-70C | 15-Nov-18 | Abbott Architect | 14.62 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076455111018DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 33 Y | Male | Non-Hispanic | <-70C | 10-Nov-18 | Abbott Architect | 11.29 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076456110518DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 37 Y | Female | Unknown | <-70C | 05-Nov-18 | Abbott Architect | 4.64 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076457110418DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 51 Y | Male | Non-Hispanic | <-70C | 04-Nov-18 | Abbott Architect | 6.57 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076458110818DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 64 Y | Male | Non-Hispanic | <-70C | 08-Nov-18 | Abbott Architect | 1.04 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076459111518DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 59 Y | Male | Non-Hispanic | <-70C | 15-Nov-18 | Abbott Architect | 5.83 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900076469111618DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 29 Y | Male | Non-Hispanic | <-70C | 16-Nov-18 | Abbott Architect | 14.08 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900082214121118DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 37 Y | Male | Non-Hispanic | <-70C | 11-Dec-18 | Abbott Architect | 16.67 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900082218121218DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 59 Y | Female | Non-Hispanic | <-70C | 12-Dec-18 | Abbott Architect | 13.43 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900082219121318DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 69 Y | Male | Non-Hispanic | <-70C | 13-Dec-18 | Abbott Architect | 11.12 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900082221121618DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 52 Y | Female | Non-Hispanic | <-70C | 16-Dec-18 | Abbott Architect | 12.94 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900084586123118DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 48 Y | Female | Non-Hispanic | <-70C | 31-Dec-18 | Abbott Architect | 2.8 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900084593120818DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $75.00 | 27 Y | Male | Non-Hispanic | <-70C | 08-Dec-18 | Abbott Architect | 13.55 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AI900085007103117DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 2.25 | 1.00 | $75.00 | 27 Y | Female | Non-Hispanic | <-70C | 31-Oct-17 | Abbott Architect | Positive | HCV | $75.00 | Unknown | 01.09.18 | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-AM900050645042317DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.75 | 1.00 | $75.00 | Female | Unknown | <-70C | 23-Apr-17 | RT-PCR | Positive | HCV | HCV RNA Quantitation 885 IU/mL | HCV Log 2.9 | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-BU900050684111612DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 49 Y | Female | Non-Hispanic | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Sexually transmited diseases (STD); Body punctures (Piercing); Haemodialysis patient | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-BU900064063050912DD | Hepatitis C (HCV) | United States | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 49 Y | Female | Non-Hispanic | <-70C | 09-May-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | Sexual contacts of HBV or HCV infected person; Sexually transmitted diseases (STD); Intravenous drug user; Body punctures (Tattooing); Household contacts of HBV or HCV infected person | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-CJ900023218080912DD | Hepatitis C (HCV) | Italy | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 75 Y | Female | Unknown | <-70°C | 09-Aug-12 | Abbott Realtime PCR | 6,140,000 IU/mL | HCV | $200.00 | Unknown | Fatigue | No | No | Dental Care Surgery | ALT: 60 AST: 87 Bilirubin: 0.8 Serum Creatinine: 0.84 mg/dL Liver Disease Diagnosis: 1995 Chronic Hepatitis | anti HCV+ (Abbott) | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900028246061714DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 36 Y | Male | Non-Hispanic | < -70C | 17-Jun-14 | Roche cobas | 15,800,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | No | Yes Tenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mg | Sexual Transmission; IV Drug Abuse | ALT: 26; AST: 26; Serum Creatinine: 87 umol/L | HBsAg+; Anti HCV+ (Elisa) | HIV+ 2012 | |||||||||||||||||||||||||||||||||||||
| BBS0005-CV900028248052814DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 5.00 | $200.00 | 43 Y | Male | Non-Hispanic | < -70C | 28-May-14 | Roche cobas | 7,120,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | Yes | Yes Tenofovir 300 mg; Lamivudine 150 mg; Aluvia 200/50 mg | Sexual Transmission; IV Drug Abuse | ALT: 83; AST: 73; Bilirubin: 903 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2005 | |||||||||||||||||||||||||||||||||||||
| BBS0005-CV900032014022417DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 54 Y | Male | Non-Hispanic | <-70C | 24-Feb-17 | Roche Cobas | 1,490,000 IU/mL | HCV Ab | $200.00 | Unknown | Fatigue; Jaundice | No | No None | Unknown | ALT: 80 U/L , AST: 118 U/L, Bilirubin: 8 umol/L, Serum Creatinine: 69 umol/L, HCV 2017 21-Feb-17 | Anti HCV + | None | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900032021112416DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 11.00 | $200.00 | 54 Y | Male | Non-Hispanic | <-70°C | 24-Nov-16 | Roche cobas | 120,000 IU/mL | 21-Nov-16 | $200.00 | Unknown | Decreased appetite; Fatigue | No | No | Unknown | ALT: 63 U/L; AST: 46 U/L; Bilirubin: 18 umol/L; Serum Creatinine: 83 umol/L 21-Nov-16 | HCV Ab + (cobas 6000E) 21-Nov-16 | N/A | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900037451021215DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 49 Y | Female | Non-Hispanic | <-70°C | 12-Feb-15 | Roche cobas | 5,500,000 copies/mL | 5-Feb-15 | $200.00 | Unknown | Decreased Appetite; Fatigue; Abdominal Pain | No | Yes | Sexual Transmission | ALT: 298 U/L; AST: 135 U/L; Serum Creatinine: 58 umol/L 16-Dec-14 | HBsAg -; Anti HCV + (Elisa) 16-Dec-14 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900037454020215DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 38 Y | Male | Non-Hispanic | < -70C | 02-Feb-15 | Roche cobas | 3,050,000 copies/mL | 7-Oct-14 | $200.00 | Unknown | No symptoms | No | Yes Tenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mg | IV Drug Abuse | ALT: 47 U/L; AST: 62 U/L; Serum Creatinine: 84 umol/dL 13-Jan-15 | HBsAg -; Anti HCV + (Elisa) 28-Oct-14 | HIV Positive 10-Oct-14 | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900041866061914DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 5.00 | $200.00 | 31 Y | Male | Non-Hispanic | < -70C | 19-Jun-14 | Roche cobas | 4,800,000 copies/mL | HCV | $200.00 | Unknown | Decreased appetite | Partial | Yes Tenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mg | IV Drug Abuse | ALT: 177; AST: 115; Serum Creatinine: 67 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2005 | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900041867031414DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 40 Y | Male | Non-Hispanic | < -70C | 14-Mar-14 | Roche cobas | 9,000,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | Yes | Yes Zidovudine 300 mg Lamivudine 150 mg Efavirenz 600 mg | Sexual Transmission; IV Drug Abuse | ALT: 102; AST: 130 | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2010 | |||||||||||||||||||||||||||||||||||||
| BBS0005-CV900047642051614DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 54 Y | Male | Non-Hispanic | < -70C | 16-May-14 | Roche cobas | 68,200 copies/mL | HCV | $200.00 | Unknown | Decreased appetite; Abdominal pain; Sleep disturbances; Nausea | No | No | Unknown | ALT: 539; AST: 414; ALP: 141; Bilirubin: 218 umol/L; Serum Creatinine: 0.64 mg/dL | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900047643071514DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 32 Y | Male | Non-Hispanic | < -70C | 15-Jul-14 | Roche cobas | 18,800,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | No | Yes Tenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mg | Sexual Transmission | ALT: 178; AST: 121; Serum Creatinine: 77umol/L 1-Jul-14 | HBsAg -; Anti HCV + (Elisa) 25-Aug-10 | HIV+ 16-Aug-10 | |||||||||||||||||||||||||||||||||||||
| BBS0005-CV900047644052814DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 6.00 | $200.00 | 32 Y | Male | Non-Hispanic | < -70C | 28-May-14 | Roche cobas | 300,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | Yes | Yes Tenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mg | Sexual Transmission; IV Drug Abuse | ALT: 50; AST: 46; Serum Creatinine: 77 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2007 | |||||||||||||||||||||||||||||||||||||
| BBS0005-CV900047645091614DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 6.00 | $200.00 | 54 Y | Male | Non-Hispanic | < -70C | 16-Sep-14 | Roche cobas | 3,700,000 IU/mL | 28-Aug-14 | Real-Time PCR | 1 | 13-Oct-14 | $200.00 | Unknown | Decreased appetite; Fatigue; Abdominal pain | No | No | Unknown | ALT: 28; AST: 63; Bilirubin: 17 umol/L; Serum Creatinine: 1.14 mg/dL 12-Sep-14 | TB+ 2013 | ||||||||||||||||||||||||||||||||||||
| BBS0005-CV900047647031914DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 8.00 | $200.00 | 66 Y | Female | Non-Hispanic | < -70C | 19-Mar-14 | Roche cobas | 950 IU/mL | 10-Mar-14 | $200.00 | Unknown | Abdominal pain; Joint pain; Sleep disturbances | No | No | Unknown | ALT: 17; AST: 11; Bilirubin: 27 umol/L 11-Mar-14 | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900056101120613DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 34 Y | Male | Non-Hispanic | < -70C | 06-Dec-13 | Roche cobas | 70,000,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | Yes | Yes Tenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mg | IV Drug Abuse | ALT: 115 U/L; AST: 66 U/L; Serum Creatinine: 81 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2013 | |||||||||||||||||||||||||||||||||||||
| BBS0005-CV900057171082114DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 57 Y | Male | Non-Hispanic | < -70C | 21-Aug-14 | Roche cobas | 11,600,000 IU/mL | 7-May-14 | $200.00 | Unknown | Fatigue; Abdominal pain; Jaundice | No | No | Unknown | ALT: 646; AST: 977; Serum Creatinine: 1.02 mg/dL 5-Aug-14 | Anti HCV + (Elisa) 5-Aug-14 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900060031072413DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 5.00 | $200.00 | 35 Y | Male | Non-Hispanic | < -70C | 24-Jul-13 | Roche cobas | 1,180,000 IU/mL | HCV | $200.00 | Unknown | Fatigue; Abdominal pain; Jaundice | No | No | IV Drug Abuse | ALT: 153 U/L; AST: 163 U/L; Bilirubin: 17 umol/L; Serum Creatinine: 95 umol/L | HIV+ 2004 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900062422112113DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 1.00 | $200.00 | 32 Y | Male | Non-Hispanic | < -70C | 21-Nov-13 | Roche cobas | 19,700,000 copies/mL | HCV | $200.00 | Unknown | No symptoms | Yes | Yes Tenofovir 300 mg Lamivudine 150 mg Nevirapine 200 mg | Unknown | ALT: 25 U/L; AST: 29 U/L; Bilirubin: 7.2 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2011 | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900063250110116DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 11.00 | $200.00 | 52 Y | Female | Non-Hispanic | <-70°C | 01-Nov-16 | Roche cobas | 11,700 IU/mL | 26-Oct-16 | $200.00 | Unknown | Decreased appetite; Fatigue | No | No | Unknown | ALT: 79 U/L; AST: 307 U/L; Bilirubin: 38.6 umol/L; Serum Creatinine: 77 umol/L 31-Oct-16 | HCV Ab + (cobas 6000E) 21-Oct-16 | N/A | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900064086050914DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 6.00 | $200.00 | 47 Y | Female | Non-Hispanic | < -70C | 09-May-14 | Roche cobas | 4,660,000 IU/mL | HCV | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice; Sleep disturbances; Depression | No | No | Unknown | ALT: 19; AST: 18; Bilirubin: 7.3 umol/L; Serum Creatinine: 0.6 mg/dL | ||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900064087050814DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 36 Y | Male | Non-Hispanic | < -70C | 08-May-14 | Roche cobas | 3,550,000 copies/mL | HCV | $200.00 | Unknown | No symptoms | No | Yes Zidovudine 300 mg Lamivudine 150 mg Efavirenz 600 mg | Sexual Transmission | ALT: 108; AST: 61 | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2012 | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900066353112715DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 48 Y | Male | Non-Hispanic | <-70°C | 27-Nov-15 | Real-Time PCR | Unknown | HCV | $200.00 | Unknown | No symptoms | ||||||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900067327051315DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 52 Y | Male | Non-Hispanic | <-70°C | 13-May-15 | Roche cobas | 97,600 IU/mL | 4-May-15 | $200.00 | Unknown | Decreased appetite; Fatigue | No | No | Unknown | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900067697051217DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 45 Y | Male | Non-Hispanic | <-70C | 12-May-17 | Roche Cobas | 45,000 IU/mL | HCV Ab | $200.00 | Unknown | Fatigue; Sleep disturbances | No | None | U/A | ALT: 25 U/L | AST: 32 U/L | Serum Creatinine: 65 umol/L 3-May-17 | HCV Ab + | COBAS 6000E 3-May-17 | Not Detected 23-May-17 | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900067700111616DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 44 Y | Male | Non-Hispanic | <-70°C | 16-Nov-16 | Roche cobas | 1,170,000 IU/mL | 15-Nov-16 | $200.00 | Unknown | Abdominal pain; Jaundice | No | No | Unknown | ALT: 26 U/L; AST: 22 U/L 13-Nov-16 | HCV Ab + (cobas 6000E) 16-Sep | N/A | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900069479072314DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 66 Y | Male | Non-Hispanic | < -70C | 23-Jul-14 | Roche cobas | 16,800 IU/mL | 9-Jul-14 | $200.00 | Unknown | Fatigue; Abdominal pain; Jaundice | No | No | Unknown | ALT: 117; AST: 141; Bilirubin: 72.4 umol/L; Serum Creatinine: 0.8 mg/dL 1-Jul-14 | Anti HCV + Elisa 2-Jul-14 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900071814010915DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 6.00 | $200.00 | 36 Y | Male | Non-Hispanic | < -70C | 09-Jan-15 | Roche cobas | 1,710,000 IU/mL | 6-Jan-14 | $200.00 | Unknown | No symptoms | No | Yes Tenofovir; Lamivudine; Efavirenz | IV Drug Abuse | None | None | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900071816030515DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 5.00 | $200.00 | 30 Y | Male | Non-Hispanic | <-70°C | 05-Mar-15 | Roche cobas | 1,360 IU/mL | 4-Mar-15 | $200.00 | Unknown | Fatigue; Jaundice | Partial | No | Unknown | ALT: 563 U/L; AST: 922 U/L; Bilirubin: 394 umol/L; Serum Creatinine: 79.8 umol/L 12-Feb-15 | None | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900071824013015DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | $200.00 | 36 Y | Female | Non-Hispanic | < -70C | 30-Jan-15 | Roche cobas | 26,700 copies/mL | HCV | $200.00 | Unknown | No symptoms | Yes | No None | Unknown | ALT: 145 U/L; AST: 57 U/L; Bilirubin: 10.9 umol/L; Serum Creatinine: 63 umol/dL 9-Jan-15 | None | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900071827051215DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 38 Y | Female | Non-Hispanic | <-70°C | 12-May-15 | Roche cobas | 5,050,000 copies/mL | 26-Apr-15 | $200.00 | Unknown | Decreased appetite; Fatigue | No | No | Unknown | |||||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077146110614DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 6.00 | $200.00 | 39 Y | Male | Non-Hispanic | < -70C | 06-Nov-14 | Roche cobas | 3,570,000 IU/mL | 1-Nov-14 | $200.00 | Unknown | Fatigue; Jaundice; Flu-like symptoms | No | No | Unknown | ALT: 267 U/L; AST: 615 U/L; Bilirubin: 207 umol/L; Serum Creatinine: 0.8 mg/dL 29-Oct-14 | Anti HCV + (Cobas) 24-Oct-14 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077151032015DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 8.00 | $200.00 | 49 Y | Female | Non-Hispanic | <-70°C | 20-Mar-15 | Roche cobas | 2,000,000 IU/mL | 10-Mar-15 | $200.00 | Unknown | Fatigue; Jaundice | Partial | No | Unknown | ALT: 5 U/L; AST: 35 U/L; Bilirubin: 6.3 umol/L; Serum Creatinine: 48 umol/L 20-Mar-15 | None | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077234060214DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 40 Y | Male | Non-Hispanic | < -70C | 02-Jun-14 | Roche cobas | 285,000 copies/mL | $200.00 | Unknown | No symptoms | No | Yes Tenofovir 300 mg; Lamivudine 300 mg; Efavirenz 600 mg | IV Drug Abuse | ALT: 36; AST: 46; Serum Creatinine: 83 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2010 | |||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077237031314DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 15.00 | $200.00 | 39 Y | Male | Non-Hispanic | < -70C | 13-Mar-14 | Roche cobas | 173,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | No | No | IV Drug Abuse | ALT: 85 U/L; AST: 257 U/L | Anti HCV+ (Elisa) | HIV+ 2013 | |||||||||||||||||||||||||||||||||||||
| BBS0005-CV900077297111816DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 10.00 | $200.00 | 46 Y | Male | Non-Hispanic | <-70°C | 18-Nov-16 | Roche HCV Monitor | 230,000 copies/mL | 16-Nov-16 | $200.00 | Unknown | Fatigue; Jaundice; Itching; Sleep disturbances | No | Yes Tenofovir; Lamivudine; Efavirenz | Sexual Transmission | ALT: 50 U/L; AST: 56 U/L; Serum Creatinine: 86 umol/L 9-Jul-16 | N/A | HIV+ 5-Jun | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900078361030617DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 36 Y | Male | Non-Hispanic | <-70C | 06-Mar-17 | Roche Cobas | 400 IU/mL | HCV Ab | $200.00 | Unknown | Decreased appetite; Fatigue | No | No None | Unknown | ALT: 51 U/L, AST: 32 U/L, ALP: 85 U/L, LDH: 150 U/L, Bilirubin: 32.6 umol/L, Chronic HCV 2016 2-Mar-17 | None | None | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900089039041417DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 2.00 | $200.00 | 39 Y | Male | Non-Hispanic | <-70C | 14-Apr-17 | Roche Cobas | 26,000,000 IU/mL | HCV Ab | $200.00 | Unknown | Fatigue; Jaundice | No | No None | IV Drug Abuse | ALT: 82 U/L, AST: 67 U/L, Bilirubin: 82 umol/L, Serum Creatinine: 72 umol/L, Chronic HCV 10-Apr-17 | HCV Ab + | AIDS+ 16-Dec | ||||||||||||||||||||||||||||||||||||||
| BBS0005-CV900089042112416DD | Hepatitis C (HCV) | Vietnam | 0.5 mL Serum | 1.00 | 8.00 | $200.00 | 52 Y | Female | Non-Hispanic | <-70°C | 24-Nov-16 | Roche HCV Monitor | 11,700 IU/mL | 21-Nov-16 | $200.00 | Unknown | Decreased appetite; Fatigue; Abdominal pain; Jaundice | No | No | Unknown | ALT: 833 U/L; AST: 1301 U/L; Bilirubin: 137.8 umol/L; Serum Creatinine: 68 umol/L 15-Nov-16 | HCV Ab + (cobas 6000E) 10-Nov-16 | N/A | ||||||||||||||||||||||||||||||||||||||
| BBS0005-DN900020563031518DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 41 Y | Female | Unknown | <-70C | 15-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 34.6 | Negative | 0.164 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-DN900025712031518DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 51 Y | Female | Unknown | <-70C | 15-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 35.5 | Negative | 0.259 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-DN900025720030918DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 52 Y | Female | Unknown | <-70C | 09-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 26.6 | Positive | 3.37 | U/A | Negative | U/A | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-DN900030994031218DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 24 Y | Female | Unknown | <-70C | 12-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 5.39 | Negative | 0.138 | U/A | Negative | U/A | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-DN900035345030718DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 21 Y | Female | Unknown | <-70C | 07-Mar-18 | Roche cobas 602 | ECLIA | 0.03 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 37.3 | Positive | 1.15 | Not Detected | Negative | Not Detected | ||||||||||||||||||||||||||||||||||||
| BBS0005-DN900035348032218DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 30 Y | Female | Unknown | <-70C | 22-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 1.27 | Positive | 10.2 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-DN900038937030918DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 56 Y | Female | Unknown | <-70C | 09-Mar-18 | Roche cobas 602 | ECLIA | 0.03 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 30.6 | Negative | 0.0801 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-DN900041046031618DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 52 Y | Female | Unknown | <-70C | 16-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 34.3 | Positive | 2.32 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-DN900053862030618DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 30 Y | Female | Unknown | <-70C | 06-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | Not Detected | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 47 | Negative | 0.0653 | Not Detected | U/A | Not Detected | ||||||||||||||||||||||||||||||||||||
| BBS0005-DN900068311030618DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 38 Y | Female | Unknown | <-70C | 06-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 14.4 | Negative | 0.132 | U/A | Negative | U/A | ||||||||||||||||||||||||||||||||||||||
| BBS0005-DN900068314031918DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.25 | 1.00 | $75.00 | 46 Y | Female | Unknown | <-70C | 19-Mar-18 | Roche cobas 602 | ECLIA | 0.03 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 50.6 | Negative | 0.0851 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| BBS0005-DN900072553031318DD | Hepatitis C (HCV) | 0.5 mL Serum | 1.50 | 1.00 | $75.00 | 40 Y | Female | Unknown | <-70C | 13-Mar-18 | Roche cobas 602 | ECLIA | 0.04 | Hepatitis C | T. Vaginalis | U/A | Anti HSV 1 IgG | Positive | $75.00 | Unknown | 31.3 | Negative | 0.158 | Not Detected | Negative | Not Detected | Non Reactive | |||||||||||||||||||||||||||||||||||
| CIT0000-CQ900068556062708DD | Hepatitis C (HCV) | South Africa | Citrated Plasma | 1.00 | 2.00 | $75.00 | 25 Y | Male | Non-Hispanic | < -70C | 27-Jun-08 | Roche cobas | 999 IU/mL | Siemens Versant Lipa | 1 / 5a | $75.00 | Unknown | ||||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032204082912DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 10.00 | $75.00 | 45 Y | Female | Unknown | < -70C | 29-Aug-12 | Roche cobas | 40,890 IU/mL | HCV Ct Value - 23 | Innogenetics INNO-LIPA | 3a | $75.00 | Unknown | Asymptomatic | 7.11 S/Co Anti-HCV | No | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032205010212DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 7.00 | $75.00 | 51 Y | Male | Unknown | < -70C | 02-Jan-12 | Roche cobas | 465,532 IU/mL | HCV Ct Value - 15 | Innogenetics INNO-LIPA | 1a | Abbott PRISM | 6.41 S/Co | Anti-HCV | $75.00 | Unknown | Asymptomatic | No | ||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032206022812DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 8.00 | $75.00 | 57 Y | Female | Unknown | < -70C | 28-Feb-12 | Roche cobas | 30,850 IU/mL | HCV Ct Value - 24 | Innogenetics INNO-LIPA | 3a | $75.00 | Unknown | Asymptomatic | 7.75 S/Co Anti-HCV | No | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032207010508DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 6.00 | $75.00 | 49 Y | Male | Unknown | < -70C | 05-Jan-08 | Roche cobas | 5,889 IU/mL | HCV Ct Value - 25 | Innogenetics INNO-LIPA | 3a | $75.00 | Unknown | Asymptomatic | 10.54 S/Co Anti-HCV | No | Immunoblot C100(4+) C33(4+) C22(4+) NS5(4+) | |||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032208101012DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 8.00 | $75.00 | 38 Y | Male | Unknown | < -70C | 10-Oct-12 | Roche cobas | 344,394 IU/mL | HCV Ct Value - 16 | Innogenetics INNO-LIPA | 1a | Abbott PRISM | 7.11 S/Co | Anti-HCV | $75.00 | Unknown | Asymptomatic | No | ||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032209072907DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 7.00 | $75.00 | 51 Y | Male | Unknown | < -70C | 29-Jul-07 | Roche cobas | 30,508 IU/mL | HCV Ct Value - 25 | Innogenetics INNO-LIPA | 1a | Abbott PRISM | 5.08 S/Co | Anti-HCV | $75.00 | Unknown | Asymptomatic | No | ||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032210110212DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 9.00 | $75.00 | 48 Y | Male | Unknown | < -70C | 02-Nov-12 | Roche cobas | 377,589 IU/mL | HCV Ct Value - 16 | Innogenetics INNO-LIPA | 1a | Abbott PRISM | 3.67 S/Co | Anti-HCV | $75.00 | Unknown | Asymptomatic | No | Immunoblot C1(4+) C2(4+) E2(2+) NS3(4+) NS4(4+) NS5(4+) | |||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032211010813DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 10.00 | $75.00 | 18 Y | Female | Unknown | < -70C | 08-Jan-13 | Roche cobas | Not detected | HCV Ct Value - 12 | Innogenetics INNO-LIPA | 1a | Abbott PRISM | 6.1 S/Co | Anti-HCV | $75.00 | Unknown | Asymptomatic | No | ||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032212102712DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 9.00 | $75.00 | 49 Y | Male | Unknown | < -70C | 27-Oct-12 | Roche cobas | 538,277 IU/mL | HCV Ct Value - 16 | Innogenetics INNO-LIPA | 1a | Abbott PRISM | 7.1 S/Co | Anti-HCV | $75.00 | Unknown | Asymptomatic | No | ||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032213112412DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 42 Y | Male | Unknown | < -70C | 24-Nov-12 | Roche cobas | 816,427 IU/mL | HCV Ct Value - 22 | Innogenetics INNO-LIPA | 3a | $75.00 | Unknown | Asymptomatic | 5.71 S/Co Anti-HCV | No | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900032214051510DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 19.00 | $75.00 | 26 Y | Female | Unknown | < -70C | 15-May-10 | Roche cobas | 402,570 IU/mL | HCV Ct Value - 16 | Innogenetics INNO-LIPA | 1a | Abbott PRISM | 7.38 S/Co | Anti-HCV | $75.00 | Unknown | Asymptomatic | No | Immunoblot C100(4+) C33(4+) C22(-) NS5(-) | |||||||||||||||||||||||||||||||||||||
| CIT0000-CS900041724071312DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 10.00 | $75.00 | 44 Y | Female | Unknown | <-70°C | 13-Jul-12 | Roche cobas | 2,642,943 IU/mL | HCV Ct Value - 11 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 7.85 Abbott PRISM | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900041725072812DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 7.00 | $75.00 | 54 Y | Male | Unknown | <-70°C | 28-Jul-12 | Roche cobas | 1,204,692 IU/mL | HCV Ct Value - 15 | Innogenetics INNO-LIPA | 1b | Immunoblot | C1(3+) C2(2+) E2(-) NS3(4+) NS4(4+) NS5(2+) | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 6.09 Abbott PRISM | |||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900041726081812DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 7.00 | $75.00 | 47 Y | Male | Unknown | <-70°C | 18-Aug-12 | Roche cobas | 491,061 IU/mL | HCV Ct Value - 15 | Innogenetics INNO-LIPA | 1a | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 5.64 Abbott PRISM | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900041735082512DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 10.00 | $75.00 | 44 Y | Male | Unknown | <-70°C | 25-Aug-12 | Roche cobas | 1,179,766 IU/mL | HCV Ct Value - 15 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 7.87 Abbott PRISM | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047443120903DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 47 Y | Male | Unknown | <-70°C | 09-Dec-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047445022003DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 42 Y | Male | Unknown | <-70°C | 20-Feb-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047446031805DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 39 Y | Female | Unknown | <-70°C | 18-Mar-05 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(3+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047447030603DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 35 Y | Female | Unknown | <-70°C | 06-Mar-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(1+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047448031504DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 37 Y | Male | Unknown | <-70°C | 15-Mar-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(3+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047449041903DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 52 Y | Female | Unknown | <-70°C | 19-Apr-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047450030403DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 27 Y | Female | Unknown | <-70°C | 04-Mar-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047451100303DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 49 Y | Female | Unknown | <-70°C | 03-Oct-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047452050303DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 35 Y | Female | Unknown | <-70°C | 03-May-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047453051403DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 45 Y | Male | Unknown | <-70°C | 14-May-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(3+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900047454052103DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 40 Y | Male | Unknown | <-70°C | 21-May-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(3+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050535020103DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 53 Y | Male | Unknown | < -70C | 01-Feb-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050536090807DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 40 Y | Female | Unknown | < -70C | 08-Sep-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(3+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050537111803DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 54 Y | Male | Unknown | < -70C | 18-Nov-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050538101503DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 31 Y | Female | Unknown | < -70C | 15-Oct-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050539030403DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 37 Y | Male | Unknown | < -70C | 04-Mar-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(4+) c33(1+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050540061404DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 37 Y | Male | Unknown | < -70C | 14-Jun-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050541040604DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 25 Y | Male | Unknown | < -70C | 06-Apr-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050542051303DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 43 Y | Male | Unknown | < -70C | 13-May-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050543092003DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 35 Y | Male | Unknown | < -70C | 20-Sep-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(-) c33(4+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050544100403DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 34 Y | Female | Unknown | < -70C | 04-Oct-03 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | $75.00 | Unknown | c100(+/-) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050545070607DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 40 Y | Female | Unknown | < -70C | 06-Jul-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(1+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050546082007DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 38 Y | Female | Unknown | < -70C | 20-Aug-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050547083007DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 52 Y | Female | Unknown | < -70C | 30-Aug-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900050548072004DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 35 Y | Male | Unknown | < -70C | 20-Jul-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056984042304DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 31 Y | Male | Unknown | < -70C | 23-Apr-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056985010704DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 41 Y | Male | Unknown | < -70C | 07-Jan-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056986050504DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 60 Y | Female | Unknown | < -70C | 05-May-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(2+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056987011004DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 38 Y | Female | Unknown | < -70C | 10-Jan-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056988092304DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 55 Y | Female | Unknown | < -70C | 23-Sep-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056989051204DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 41 Y | Female | Unknown | < -70C | 12-May-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(3+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056990031104DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 40 Y | Female | Unknown | < -70C | 11-Mar-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(+/-) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056991042404DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 37 Y | Male | Unknown | < -70C | 24-Apr-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(3+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056992021204DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 34 Y | Male | Unknown | < -70C | 12-Feb-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Negative | $75.00 | Unknown | c100(4+) c33(4+) c22(2+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056993071204DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 34 Y | Male | Unknown | < -70C | 12-Jul-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056994031104DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 59 Y | Male | Unknown | < -70C | 11-Mar-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056995031104DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 59 Y | Female | Unknown | < -70C | 11-Mar-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(2+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056996041209DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 41 Y | Male | Unknown | < -70C | 12-Apr-09 | Chiron HCV RIBA | Positive | Abbott PRISM | 7.75 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900056997051210DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 51 Y | Female | Unknown | < -70C | 12-May-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 5.85 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(3+) c33(3+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063907010508DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 49 Y | Male | Unknown | < -70C | 05-Jan-08 | Chiron HCV RIBA | Positive | Abbott PRISM | 10.54 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063908070210DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 62 Y | Male | Unknown | < -70C | 02-Jul-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 6.05 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063909022708DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 50 Y | Male | Unknown | < -70C | 27-Feb-08 | Chiron HCV RIBA | Positive | Abbott PRISM | 9.69 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063910012910DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 19 Y | Female | Unknown | < -70C | 29-Jan-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 6.66 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063911011008DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 24 Y | Male | Unknown | < -70C | 10-Jan-08 | Chiron HCV RIBA | Positive | Abbott PRISM | 8.37 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(2+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063912020608DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 43 Y | Male | Unknown | < -70C | 06-Feb-08 | Chiron HCV RIBA | Positive | Abbott PRISM | 8.08 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063913062510DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 57 Y | Male | Unknown | < -70C | 25-Jun-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 6.35 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063914012808DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 50 Y | Female | Unknown | < -70C | 28-Jan-08 | Chiron HCV RIBA | Positive | Abbott PRISM | 5.47 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(+/-) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063915062710DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 1.00 | $75.00 | 44 Y | Male | Unknown | < -70C | 27-Jun-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 6.67 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(-) c33(2+) c22(3+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063916111304DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 27 Y | Male | Unknown | < -70C | 13-Nov-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(-) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063917052904DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 37 Y | Male | Unknown | < -70C | 29-May-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(3+) c33(2+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063918112107DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 35 Y | Male | Unknown | < -70C | 21-Nov-07 | Chiron HCV RIBA | Positive | Abbott PRISM | 9.63 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063919031707DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 49 Y | Male | Unknown | < -70C | 17-Mar-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900063920041107DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 48 Y | Female | Unknown | < -70C | 11-Apr-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066359012012DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 41 Y | Female | Unknown | <-70°C | 20-Jan-12 | Roche cobas | 3,538,653 IU/mL | HCV Ct Value - 14 | Innogenetics INNO-LIPA | 1a | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 6.19 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066361030712DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 6.00 | $75.00 | 39 Y | Male | Unknown | <-70°C | 07-Mar-12 | Roche cobas | 916,713 IU/mL | HCV Ct Value - 17 | Innogenetics INNO-LIPA | 1a | Immunoblot | C1(4+) C2(4+) E2(3+) NS3(4+) NS4(4+) NS5(-) | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 7.22 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066362062212DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 45 Y | Male | Unknown | <-70°C | 22-Jun-12 | Roche cobas | 685,173 IU/mL | HCV Ct Value - 15 | Innogenetics INNO-LIPA | 1a | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 5.32 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066363061312DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 6.00 | $75.00 | 50 Y | Male | Unknown | <-70°C | 13-Jun-12 | Roche cobas | 8,795,263 IU/mL | HCV Ct Value - 11 | Innogenetics INNO-LIPA | 1a | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 8.09 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066364061611DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 11.00 | $75.00 | 39 Y | Male | Unknown | <-70°C | 16-Jun-11 | Roche cobas | 289,778 IU/mL | HCV Ct Value - 11 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 7.79 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066365072211DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 8.00 | $75.00 | 47 Y | Female | Unknown | <-70°C | 22-Jul-11 | Roche cobas | 87,452 IU/mL | HCV Ct Value - 23 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 5.35 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066366081111DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 9.00 | $75.00 | 44 Y | Female | Unknown | <-70°C | 11-Aug-11 | Roche cobas | 665,224 IU/mL | HCV Ct Value - 21 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 5.05 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066367012012DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 8.00 | $75.00 | 35 Y | Male | Unknown | <-70°C | 20-Jan-12 | Roche cobas | 1,289,638 IU/mL | HCV Ct Value - 14 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 6.15 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066374012812DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 11.00 | $75.00 | 43 Y | Male | Unknown | <-70°C | 28-Jan-12 | Roche cobas | 3,951,173 IU/mL | HCV Ct Value - 19 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 7.2 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066375042312DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 11.00 | $75.00 | 62 Y | Female | Unknown | <-70°C | 23-Apr-12 | Roche cobas | 33,879 IU/mL | HCV Ct Value - 15 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 8.33 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066376042412DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 9.00 | $75.00 | 45 Y | Male | Unknown | <-70°C | 24-Apr-12 | Roche cobas | 611,136 IU/mL | HCV Ct Value - 19 | Innogenetics INNO-LIPA | 1b | Immunoblot | C1(4+) C2(3+) E2(3+) NS3(3+) NS4(-) NS5(-) | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 5.18 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066377062012DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 6.00 | $75.00 | 45 Y | Male | Unknown | <-70°C | 20-Jun-12 | Roche cobas | 4,467,154 IU/mL | HCV Ct Value - 15 | Innogenetics INNO-LIPA | 1b | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 7.91 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900066378041812DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 7.00 | $75.00 | 49 Y | Male | Unknown | <-70°C | 18-Apr-12 | Roche cobas | 404,479 IU/mL | HCV Ct Value - 21 | Innogenetics INNO-LIPA | 3a | $75.00 | Unknown | Asymptomatic | Anti-HCV S/CO - 6.28 (Abbott PRISM) | |||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068723012407DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 54 Y | Male | Unknown | < -70C | 24-Jan-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Negative | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068724122106DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 30 Y | Male | Unknown | < -70C | 21-Dec-06 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068725120906DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 29 Y | Male | Unknown | < -70C | 09-Dec-06 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068726111706DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 51 Y | Female | Unknown | < -70C | 17-Nov-06 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(2+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068727042607DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 2.00 | $75.00 | 62 Y | Female | Unknown | < -70C | 26-Apr-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068728020807DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 35 Y | Male | Unknown | < -70C | 08-Feb-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068729121306DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 40 Y | Female | Unknown | < -70C | 13-Dec-06 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068730020307DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 61 Y | Male | Unknown | < -70C | 03-Feb-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(3+) c33(4+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068731053107DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 43 Y | Male | Unknown | < -70C | 31-May-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068732112506DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 39 Y | Male | Unknown | < -70C | 25-Nov-06 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068733120206DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 44 Y | Male | Unknown | < -70C | 02-Dec-06 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068734102304DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 54 Y | Male | Unknown | < -70C | 23-Oct-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068735113004DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 38 Y | Male | Unknown | < -70C | 30-Nov-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900068736112004DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 28 Y | Female | Unknown | < -70C | 20-Nov-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(-) c33(4+) c22(4+) NS5(2+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073168081604DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 45 Y | Male | Unknown | < -70C | 16-Aug-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073169052704DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 42 Y | Female | Unknown | < -70C | 27-May-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073170041807DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 18 Y | Female | Unknown | < -70C | 18-Apr-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(+/-) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073171090307DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 43 Y | Female | Unknown | < -70C | 03-Sep-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073172010305DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 5.00 | $75.00 | 53 Y | Female | Unknown | < -70C | 03-Jan-05 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073173091804DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 24 Y | Male | Unknown | < -70C | 18-Sep-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Negative | $75.00 | Unknown | c100(2+) c33(+/-) c22(3+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073174040507DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 59 Y | Female | Unknown | < -70C | 05-Apr-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(4+) NS5(2+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073175032107DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 41 Y | Male | Unknown | < -70C | 21-Mar-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073176100407DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 40 Y | Male | Unknown | < -70C | 04-Oct-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073177040407DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 32 Y | Male | Unknown | < -70C | 04-Apr-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073178112807DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 42 Y | Female | Unknown | < -70C | 28-Nov-07 | Chiron HCV RIBA | Positive | Abbott PRISM | 5.95 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073179101704DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 45 Y | Male | Unknown | < -70C | 17-Oct-04 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073180032607DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 38 Y | Female | Unknown | < -70C | 26-Mar-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900073181020207DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 38 Y | Male | Unknown | < -70C | 02-Feb-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078908052607DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 41 Y | Male | Unknown | < -70C | 26-May-07 | Chiron HCV RIBA | Positive | Abbott PRISM | Positive | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078909112010DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 28 Y | Male | Unknown | < -70C | 20-Nov-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 7.48 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078910113011DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 49 Y | Female | Unknown | < -70C | 30-Nov-11 | Chiron HCV RIBA | Positive | Abbott PRISM | 1.73 S/Co | HCV RNA | Negative | $75.00 | Unknown | c100(2+) c33(2+) c22(2+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078911021312DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 38 Y | Male | Unknown | < -70C | 13-Feb-12 | Chiron HCV RIBA | Positive | Abbott PRISM | 6.9 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078912122211DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 59 Y | Female | Unknown | < -70C | 22-Dec-11 | Chiron HCV RIBA | Positive | Abbott PRISM | 1.12 S/Co | HCV RNA | Negative | $75.00 | Unknown | c100(3+) c33(2+) c22(-) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078913121011DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 5.00 | $75.00 | 41 Y | Male | Unknown | < -70C | 10-Dec-11 | Chiron HCV RIBA | Positive | Abbott PRISM | 8.53 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078914040212DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 5.00 | $75.00 | 39 Y | Female | Unknown | < -70C | 02-Apr-12 | Chiron HCV RIBA | Positive | Abbott PRISM | 3.69 S/Co | HCV RNA | Negative | $75.00 | Unknown | c100(2+) c33(3+) c22(1+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078915111310DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 38 Y | Male | Unknown | < -70C | 13-Nov-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 8.15 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(2+) c33(4+) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078916100411DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 5.00 | $75.00 | 44 Y | Male | Unknown | < -70C | 04-Oct-11 | Chiron HCV RIBA | Positive | Abbott PRISM | 7.57 S/Co | HCV RNA | Negative | $75.00 | Unknown | c100(+/-) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078917011411DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 5.00 | $75.00 | 25 Y | Male | Unknown | < -70C | 14-Jan-11 | Chiron HCV RIBA | Positive | Abbott PRISM | 5.4 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(2+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078918091311DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 47 Y | Male | Unknown | < -70C | 13-Sep-11 | Chiron HCV RIBA | Positive | Abbott PRISM | 2 S/Co | HCV RNA | Negative | $75.00 | Unknown | c100(2+) c33(2+) c22(3+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078919112010DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 29 Y | Female | Unknown | < -70C | 20-Nov-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 6.09 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078920112010DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 3.00 | $75.00 | 33 Y | Male | Unknown | < -70C | 20-Nov-10 | Chiron HCV RIBA | Positive | Abbott PRISM | 8.35 S/Co | HCV RNA | Positive | $75.00 | Unknown | c100(4+) c33(4+) c22(4+) NS5(4+) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-CS900078921080511DD | Hepatitis C (HCV) | Spain | Citrated Plasma | 1.00 | 4.00 | $75.00 | 30 Y | Female | Unknown | < -70C | 05-Aug-11 | Chiron HCV RIBA | Positive | Abbott PRISM | 2.41 S/Co | HCV RNA | Negative | $75.00 | Unknown | c100(4+) c33(+/-) c22(4+) NS5(+/-) | Negative | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900018264040211DD | Hepatitis C (HCV) | France | Citrated Plasma | 1.00 | 9.00 | $75.00 | Unknown | <-70C | 02-Apr-11 | Roche cobas | 5,455 IU/mL | Lipa 2 | 4a/4c/4d | Sequencing (Region NS5b) | 4d | $75.00 | Unknown | 5.020 | 4.970 | 5.210 | 4.96 | C1 (3+); C2(4+); E2 (2+); NS3 (4+); NS4 (4+); NS5 (--) Pos | Pos | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900018266062412DD | Hepatitis C (HCV) | France | Citrated Plasma | 1.00 | 9.00 | $75.00 | Unknown | <-70C | 24-Jun-12 | Roche cobas | 151,774 IU/mL | Lipa 2 | 4 | Sequencing (Region NS5b) | 4a | $75.00 | Unknown | 9.370 | 9.450 | 9.430 | 4.933 | C1 (4+); C2 (4+); E2 (4+); NS3 (4+); NS4 (4+);NS5 (2+) Pos | Pos | ||||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900053622061611DD | Hepatitis C (HCV) | France | Citrated Plasma | 1.00 | 3.00 | $75.00 | Unknown | <-70C | 16-Jun-11 | Roche cobas | 761,939 IU/mL | Lipa 2 | 4a/4c/4d | Sequencing (Region NS5b) | 4a | $75.00 | Unknown | 4.942 | 4.949 | 4.949 | Pos | Pos | 75.55 | HBc Positive | |||||||||||||||||||||||||||||||||||||||
| CIT0000-EQ900085558021712DD | Hepatitis C (HCV) | France | Citrated Plasma | 1.00 | 9.00 | $75.00 | 52 Y | Male | Unknown | <-70C | 17-Feb-12 | Roche cobas | 218,160 IU/mL | Lipa 2 | 4a/4c/4d | Sequencing (Region NS5b) | 4a | $75.00 | Unknown | 5.130 | 4.760 | 5.110 | 4.927 | 4.906 | 4.914 | C1 (4+), C2 (4+), E (1+), NS3 (4+), NS4 (3+), NS5 (1+) | Positive | ||||||||||||||||||||||||||||||||||||||
| DSP3800-AC900069461100112DD | Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 57 Y | Female | Unknown | <-70C | 01-Oct-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Jaundice; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | Multiple sex partners; Transplant / transfusion of unscreened blood or blood products (prior to 1992) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-AH900047460040809DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 5.00 | 26.00 | $75.00 | 28 Y | Male | Non-Hispanic | <-70C | 08-Apr-09 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-AH900047462051809DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 5.00 | 24.00 | $75.00 | 38 Y | Male | Non-Hispanic | <-70C | 18-May-09 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900032904020813DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 56 Y | Female | Non-Hispanic | <-70C | 08-Feb-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900032905012913DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 56 Y | Male | Non-Hispanic | <-70C | 29-Jan-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Sexually transmitted diseases (STD); Intravenous drug user; Institutionalized population | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900036009081413DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $200.00 | 57 Y | Female | Non-Hispanic | <-70C | 14-Aug-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine / light color feces; Elevated LFTs | Body punctures (Piercing); Transfusion of unscreened blood or blood products (prior to 1992) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900036178040213DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 50 Y | Male | Non-Hispanic | <-70C | 02-Apr-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | Sexually transmitted diseases (STD); Homosexual M; Multiple sex partners; Transfusion of unscreened blood or blood products (prior to 1992) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900042699111512DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 57 Y | Male | Non-Hispanic | <-70C | 15-Nov-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Fatigue; Dark color urine / light color feces; Elevated LFTs | Sexually transmitted diseases (STD); Homosexual M; Body punctures (Human bite); Haemodialysis patient | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900042700103012DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 45 Y | Female | Non-Hispanic | <-70C | 30-Oct-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | Body punctures (Piercing); Household contacts of HBV or HCV infected person | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900042701111212DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 53 Y | Female | Non-Hispanic | <-70C | 12-Nov-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Fatigue; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Body punctures (Tattooing, piercing); Haemodialysis patient | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900042702120612DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 61 Y | Male | Non-Hispanic | <-70C | 06-Dec-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine / light color feces; Elevated LFTs | Sexual contacts of HBV or HCV infected person; Intravenous drug user; Multiple sex partners | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900047455082613DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 58 Y | Female | Non-Hispanic | <-70C | 26-Aug-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Elevated LFTs | Intravenous drug user; Body punctures (Tattooing, piercing; human bite); Institutionalized population (Prisoner) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900050684111612DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $200.00 | 49 Y | Female | Non-Hispanic | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Sexually transmited diseases (STD); Body punctures (Piercing); Haemodialysis patient | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900052407030212DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 3.00 | $200.00 | 41 Y | Male | Non-Hispanic | <-70C | 02-Mar-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Homosexual M; Intravenous drug user; Body punctures | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900054743110512DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $200.00 | 55 Y | Female | Non-Hispanic | <-70C | 05-Nov-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | Sexually transmitted diseases (STD); Multiple sex partners; Body punctures (Piercing); Institutionalized population | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900057175062013DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 44 Y | Male | Non-Hispanic | <-70C | 20-Jun-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Weight loss; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine / light color feces; Elevated LFTs | Sexually transmitted diseases (STD) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900057178060313DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 57 Y | Male | Non-Hispanic | <-70C | 03-Jun-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Intravenous drug user | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900064063050912DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 7.00 | $200.00 | 49 Y | Female | Non-Hispanic | <-70C | 09-May-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | Sexual contacts of HBV or HCV infected person; Sexually transmitted diseases (STD); Intravenous drug user; Body punctures (Tattooing); Household contacts of HBV or HCV infected person | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900066339071613DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 23 Y | Female | Non-Hispanic | <-70C | 16-Jul-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Sexually transmitted diseases (STD); Multiple sex partners; Body punctures (Tattooing, piercing, human bite) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900074795101912DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 53 Y | Female | Non-Hispanic | <-70C | 19-Oct-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Abdominal pains; Elevated LFTs | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Body punctures (Piercing) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900074798091012DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 41 Y | Female | Non-Hispanic | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Sexually transmitted diseases (STD)'; Intravenous drug user; Body punctures (Tattooing) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-BU900079078101912DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 42 Y | Female | Non-Hispanic | <-70C | 19-Oct-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | Occupational contact with blood (Medical or dental workers); Body punctures (Acupuncture, Pierciing) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-CJ900037056091112DD | Hepatitis C (HCV) | Italy | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 73 Y | Male | Non-Hispanic | <-70°C | 11-Sep-12 | Abbott Realtime PCR | 21,196 IU/mL | Siemens TruGene HCV | 1b | $200.00 | Unknown | Fatigue | No | No | Dental Care | ALT: 46; AST: 33; ALP: 44; LDH: 237; Bilirubin: 1.24; Serum Creatinine: 0.85 mg/dL; Chronic Hepatitis | anti-HCV+; anti-HBe+; HBeAg- (Abbott) | ||||||||||||||||||||||||||||||||||||||
| DSP3800-CV900039264053113DD | Hepatitis C (HCV) | Vietnam | Double Spun Plasma | 1.00 | 4.00 | $200.00 | 42 Y | Male | Non-Hispanic | <-70C | 31-May-13 | Roche TaqMan | 1,160,000 IU/mL | Real-Time PCR | 6 | 2 | $200.00 | Unknown | Decreased appetite; Fatigue; Abdominal pain; Jaundice; Itching | No | No | IV Drug Abuse | ALT: 30; AST: 57; Bilirubin: 187.2 umol/L; Serum Creatinine: 65 umol/L; Hepatits C co-infection B | HBsAg+; HBeAg- (ECLIA Cobas 6000) | HBV + | |||||||||||||||||||||||||||||||||||||
| DSP3800-CV900043236122613DD | Hepatitis C (HCV) | Vietnam | Double Spun Plasma | 1.00 | 11.00 | $200.00 | 39 Y | Male | Non-Hispanic | < -70C | 26-Dec-13 | Roche cobas | 7,150,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | No | Yes Tenofovir 300 mg; Lamivudine 150 mg; Lopinavir / Ritonavir 200 mg / 50 mg | Sexual Transmission | ALT: 82 U/L; AST: 86 U/L; Serum Creatinine: 90 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2010 | |||||||||||||||||||||||||||||||||||||
| DSP3800-CV900046269060613DD | Hepatitis C (HCV) | Vietnam | Double Spun Plasma | 1.00 | 3.00 | $200.00 | 24 Y | Male | Non-Hispanic | < -70C | 06-Jun-13 | Roche cobas | 71,800 IU/mL (HCV RNA); 195,000 (HBV RNA) | Real-Time PCR | 1 | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice; Itching | Partial | No | Unknown | ALT: 178; AST: 138; Bilirubin: 57.9 umol/L; Serum Creatinine: 69 umol/L; Hepatitis C & B | HBsAg+; Anti HCV+ (ECLIA Cobas 6000) | HBV+ | |||||||||||||||||||||||||||||||||||||
| DSP3800-CV900051867122413DD | Hepatitis C (HCV) | Vietnam | Double Spun Plasma | 1.00 | 12.00 | $200.00 | 37 Y | Female | Non-Hispanic | < -70C | 24-Dec-13 | Roche cobas | 15,500,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | No | Yes Zidovudine 300 mg; Lamivudine 150 mg; Efavirenz 600 mg | IV Drug Abuse | ALT: 52 U/L; AST: 44 U/L; Serum Creatinine: 91 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2010 | |||||||||||||||||||||||||||||||||||||
| DSP3800-CV900062434122613DD | Hepatitis C (HCV) | Vietnam | Double Spun Plasma | 1.00 | 15.00 | $200.00 | 30 Y | Male | Non-Hispanic | < -70C | 26-Dec-13 | Roche cobas | 7,150,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | Asymptomatic | No | Yes Tenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mg | Sexual Transmission | ALT: 93 U/L; AST: 77 U/L; Serum Creatinine: 72 umol/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2011 | |||||||||||||||||||||||||||||||||||||
| DSP3800-CV900068509122313DD | Hepatitis C (HCV) | Vietnam | Double Spun Plasma | 1.00 | 12.00 | $200.00 | 35 Y | Male | Non-Hispanic | < -70C | 23-Dec-13 | Roche cobas | 2,360,000 copies/mL | Real-Time PCR | 1 | $200.00 | Unknown | No symptoms | No | Yes Tenofovir 300 mg; Lamivudine 150 mg; Efavirenz 600 mg | Sexual Transmission; IV Drug Abuse | ALT: 46 U/L; AST: 48 U/L | HBsAg-; Anti HCV+ (Elisa) | HIV+ 2012 | |||||||||||||||||||||||||||||||||||||
| DSP3800-EN900068512112713DD | Hepatitis C (HCV) | Italy | Double Spun Plasma | 1.00 | 1.00 | $200.00 | 58 Y | Male | Non-Hispanic | < -70C | 27-Nov-13 | Roche cobas | 8,820 IU/mL (HBV); 207,000 IU/mL (HCV) | PCR Sequencing; Siemens TruGene HCV | D (HBV); 1b (HCV) | $200.00 | Unknown | Fatigue | No | No | Sexual transmission | ALT: 81; AST: 37; LDH: 383; Bilirubin: 0.6; Serum Creatinine: 0.7 mg/dL; Grade 1 Stage 2; Chronic Active Hepatitis due to HBV & HCV | HBsAg+; HDV Ab-; HBsAb-; HCV Ab+ (CMIA) | ||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900032898082312DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 4.00 | $200.00 | 54 Y | Male | Non-Hispanic | <-70C | 23-Aug-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | Multiple sex partners | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900032900091712DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 59 Y | Male | Non-Hispanic | <-70C | 17-Sep-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Fatigue; Nausea; Light color feces; Elevated LFTs | Sexual contacts of HBV or HCV infected person; Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Institutionalized population (Past) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900032902100912DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 30 Y | Female | Non-Hispanic | <-70C | 09-Oct-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Fatigue; Dark color urine; Elevated LFTs | Multiple sex partners; Body punctures, (Tattooing & piercing); Pregnant (4.5 months) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900041695100813DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 57 Y | Female | Non-Hispanic | <-70C | 08-Oct-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Muscle or joint aches (Myalgia); Light color feces; Elevated LFTs | Sexually transmitted diseases (STD); Intravenous drug user; Body punctures; Institutionalized population | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900066335062013DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 46 Y | Male | Non-Hispanic | <-70C | 20-Jun-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Light color feces (Diarrhea); Elevated LFTs | Intravenous drug user | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900066907081213DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 40 Y | Male | Non-Hispanic | <-70C | 12-Aug-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Fatigue; Dark color urine; Elevated LFTs | Sexually transmitted diseases (STD); Intravenous drug user; Body punctures, (Human bite) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900069487051513DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 26 Y | Female | Non-Hispanic | <-70C | 15-May-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Muscle or joint aches (Myalgia); Elevated LFTs | Transplant / transfusion of blood or blood products (prior to 1992) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900069488060313DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 31 Y | Female | Non-Hispanic | <-70C | 03-Jun-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Jaundice; Fatigue; Abdominal pains; Dark color urine; Elevated LFTs | Sexual contacts of HBV or HCV infected person; Body punctures; Household contacts of HBV or HCV infected person | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900069489060413DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 5.00 | $200.00 | 22 Y | Female | Non-Hispanic | <-70C | 04-Jun-13 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Fatigue; Nausea; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | Intravenous drug user; Body punctures (Piercing) | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| DSP3800-FI900079100091312DD | Hepatitis C (HCV) | United States | Double Spun Plasma | 1.00 | 6.00 | $200.00 | 37 Y | Male | Non-Hispanic | <-70C | 13-Sep-12 | Ortho HCV 3.0 ELISA | Reactive | HCV Ab | $200.00 | Unknown | Loss of appetite; Nausea; Light color feces; Elevated LFTs | Sexually transmitted diseases (STD); Multiple sex partners; Institutionalized population | Negative | Negative | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-AH900047458032508DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 5.00 | 18.00 | $75.00 | Male | Unknown | <-70C | 25-Mar-08 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | ||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AH900050552120109DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 5.00 | 14.00 | $75.00 | 23 Y | Male | Non-Hispanic | <-70C | 01-Dec-09 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AH900067297011116DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 2.00 | $75.00 | 33 Y | Male | Non-Hispanic | <-70C | 11-Jan-16 | Abbott Prism | Positive | HCV Ab | $75.00 | O+ | Yes | Negative HBsAg, Anti-HIV I/II | Positive HCV Negative HIV, HBV | Negative RPR | |||||||||||||||||||||||||||||||||||||||||
| EDP0000-AI900095432071619DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 62 Y | Female | Non-Hispanic | <-70C | 16-Jul-19 | Abbott Architect I2000 | CMIA | 15.42 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AI900095433071519DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.50 | 1.00 | $75.00 | 62 Y | Female | Non-Hispanic | <-70C | 15-Jul-19 | Abbott Architect I2000 | CMIA | 0.8 | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AI900103674101518DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 65 Y | Female | Non-Hispanic | <-70C | 15-Oct-18 | Abbott Architect | 14.21 + | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AI900103675100818DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.50 | 1.00 | $75.00 | 46 Y | Female | Non-Hispanic | <-70C | 08-Oct-18 | Abbott Architect | 7.25 + | HCV Ab | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062063070215DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 37 Y | Male | Unknown | <-70°C | 02-Jul-15 | Roche cobas | 3,821,825 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062064072015DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.50 | 1.00 | $75.00 | 47 Y | Male | Unknown | <-70°C | 20-Jul-15 | Roche cobas | 2,277,300 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062065063015DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 2.00 | $75.00 | 57 Y | Male | Unknown | <-70°C | 30-Jun-15 | Roche cobas | 2,559,498 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062066072015DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 3.00 | $75.00 | 51 Y | Male | Unknown | <-70°C | 20-Jul-15 | Roche cobas | 1,265,458 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062067070115DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 47 Y | Male | Unknown | <-70°C | 01-Jul-15 | Roche cobas | 3,508,725 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062069071815DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 2.00 | $75.00 | 55 Y | Female | Unknown | <-70°C | 18-Jul-15 | Roche cobas | 1,496,422 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062070071815DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 39 Y | Male | Unknown | <-70°C | 18-Jul-15 | Roche cobas | 674,198 IU/mL | HCV | Roche cobas TaqMan HCV test, v2.0 | 367,240 U/mL | Hepatitis C Virus RNA Qt 04/08/2019 8:34 | Roche cobas TaqMan HCV test, v2.0 | 5.56 LogUnit/mL | Hepatitis C Virus RNA Log10 04/08/2019 8:34 | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062078070115DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 61 Y | Female | Unknown | <-70°C | 01-Jul-15 | Roche cobas | 1,101,915 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062079071715DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 41 Y | Female | Unknown | <-70°C | 17-Jul-15 | Roche cobas | 3,142,779 IU/mL | HCV | Roche cobas TaqMan HCV test, v2.0 | 2,081,907 U/mL | Hepatitis C Virus RNA Qt 04/08/2019 8:34 | Roche cobas TaqMan HCV test, v2.0 | 6.32 LogUnit/mL | Hepatitis C Virus RNA Log10 04/08/2019 8:34 | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900062080072115DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 2.00 | $75.00 | 50 Y | Male | Unknown | <-70°C | 21-Jul-15 | Roche cobas | 1,778,924 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900066948072015DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 3.00 | $75.00 | 62 Y | Male | Unknown | <-70°C | 20-Jul-15 | Roche cobas | 1,063,739 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900066949080615DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 50 Y | Male | Unknown | <-70°C | 06-Aug-15 | Roche cobas | 2,317,000 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900066950080615DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 2.00 | $75.00 | 57 Y | Female | Unknown | <-70°C | 06-Aug-15 | Roche cobas | 1,444,340 IU/mL | HCV | Roche cobas TaqMan HCV test, v2.0 | 1,259,324 U/mL | Hepatitis C Virus RNA Qt 04/08/2019 8:34 | Roche cobas TaqMan HCV test, v2.0 | 6.10 LogUnit/mL | Hepatitis C Virus RNA Log10 04/08/2019 8:34 | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900066951080615DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $75.00 | 67 Y | Male | Unknown | <-70°C | 06-Aug-15 | Roche cobas | 1,678 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900066952080615DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 1.00 | 2.00 | $75.00 | 63 Y | Male | Unknown | <-70°C | 06-Aug-15 | Roche cobas | 2,077,381 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-AX900105493080615DD | Hepatitis C (HCV) | United States | K2 EDTA Plasma | 0.75 | 1.00 | $75.00 | 53 Y | Male | Unknown | <-70°C | 06-Aug-15 | Roche cobas | 340,068 IU/mL | HCV | $75.00 | Unknown | |||||||||||||||||||||||||||||||||||||||||||||
| EDP0000-CJ900023225071912DD | Hepatitis C (HCV) | Italy | K2 EDTA Plasma | 1.00 | 1.00 | $200.00 | 57 Y | Male | Unknown | <-70°C | 19-Jul-12 | Abbott Realtime PCR | 653 IU/mL | HCV | $200.00 | Unknown | Fatigue; Jaundice | No | No | Surgery | ALT: 20; AST: 43; ALP: 300; LDH: 349; Bilirubin: 1.59; Serum Creatinine: 1.02 mg/dL; Liver Disease Diagnosis: 2005; Hepatic Cirrhosis | anti HCV+ (Abbott) | |||||||||||||||||||||||||||||||||||||||
| EDP0000-CJ900033311072412DD | Hepatitis C (HCV) | Italy | K2 EDTA Plasma | 1.00 | 2.00 | $200.00 | 68 Y | Female | Unknown | <-70°C | 24-Jul-12 | Abbott Realtime PCR | HCV/RNA Positive | HCV | $200.00 | Unknown | Fatigue | No | No | Surgery | ALT: 26; AST: 33; ALP: 48; LDH: 386; Bilirubin: 0.83; Serum Creatinine: 0.82 mg/dL; Liver Disease Diagnosis: 1983; Hepatocellular Carcinoma 2012 | anti HCV+ (Abbott) | |||||||||||||||||||||||||||||||||||||||
| EDP0000-CV900046265061113DD | Hepatitis C (HCV) | Vietnam | K2 EDTA Plasma | 1.00 | 6.00 | $200.00 | 33 Y | Male | Non-Hispanic | < -70C | 11-Jun-13 | Roche cobas | 137,000 IU/mL | HCV | $200.00 | Unknown | Fatigue | No | No | IV Drug Abuse | ALT: 33 U/L; AST: 23 U/L; Bilirubin: 11.5 umol/L; Serum Creatinine: 90 umol/L | HBsAg- (ECLIA Cobas 6000) | |||||||||||||||||||||||||||||||||||||||
| K2E0000-AH900050550042707DD | Hepatitis C (HCV) | United States | K3 EDTA | 5.00 | 37.00 | $75.00 | 34 Y | Female | Non-Hispanic | <-70C | 27-Apr-07 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive | |||||||||||||||||||||||||||||||||||||||||||
| K2E0000-AH900050554030810DD | Hepatitis C (HCV) | United States | K3 EDTA | 5.00 | 10.00 | $75.00 | 33 Y | Male | Non-Hispanic | <-70C | 08-Mar-10 | Roche COBAS AmpliScreen HCV | Positive | HCV Ab | $75.00 | Unknown | Reactive | Non Reactive |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.